oxophenylarsine has been researched along with Leukemia, Basophilic, Acute in 2 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumada, T | 1 |
| Nakashima, S | 1 |
| Miyata, H | 1 |
| Nozawa, Y | 1 |
| Massol, P | 1 |
| Montcourrier, P | 1 |
| Guillemot, JC | 1 |
| Chavrier, P | 1 |
2 other studies available for oxophenylarsine and Leukemia, Basophilic, Acute
| Article | Year |
|---|---|
Potent activation of phospholipase D by phenylarsine oxide in rat basophilic leukemia (RBL-2H3) cells.
Topics: Animals; Arsenicals; Benzoquinones; Calcium; Cell Line; Enzyme Activation; Genistein; Isoflavones; K | 1994 |
Fc receptor-mediated phagocytosis requires CDC42 and Rac1.
Topics: Animals; Arsenicals; Bacterial Proteins; Bacterial Toxins; cdc42 GTP-Binding Protein; Cell Cycle Pro | 1998 |